BackgroundGestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. It is known that GDM is associated with an altered placental function and changes in placental gene regulation. More recent studies demonstrated an involvement of epigenetic mechanisms. So far, the focus regarding placental epigenetic changes in GDM was set on gene-specific DNA methylation analyses. Studies that robustly investigated placental global DNA methylation are lacking. However, several studies showed that tissue-specific alterations in global DNA methylation are independently associated with type 2 diabetes. Thus, the aim of this study was to characterize global placental DNA methylation by robustly measuring placental DNA 5-methylcytosine (5mC) content and to examine whether differences in placental global DNA methylation are associated with GDM. MethodsGlobal DNA methylation was quantified by the current gold standard method, LC-MS/MS. In total, 1030 placental samples were analyzed in this single-center birth cohort study. ResultsMothers with GDM displayed a significantly increased global placental DNA methylation (3.22?±?0.63 vs. 3.00?±?0.46?%; p =?0.013; ±SD). Bivariate logistic regression showed a highly significant positive correlation between global placental DNA methylation and the presence of GDM ( p =?0.0009). Quintile stratification according to placental DNA 5mC levels revealed that the frequency of GDM was evenly distributed in quintiles 1–4 (2.9–5.3?%), whereas the frequency in the fifth quintile was significantly higher (10.7?%; p =?0.003). Bivariate logistic models adjusted for maternal age, BMI, ethnicity, recurrent miscarriages, and familiar diabetes predisposition clearly demonstrated an independent association between global placental DNA hypermethylation and GDM. Furthermore, an ANCOVA model considering known predictors of DNA methylation substantiated an independent association between GDM and placental DNA methylation. ConclusionsThis is the first study that employed a robust quantitative assessment of placental global DNA methylation in over a thousand placental samples. The study provides large scale evidence that placental global DNA hypermethylation is associated with GDM, independent of established risk factors.
展开▼
机译:背景妊娠糖尿病(GDM)与不良妊娠结局相关。已知GDM与胎盘功能改变和胎盘基因调节的改变有关。最近的研究表明表观遗传机制的参与。到目前为止,有关GDM胎盘表观遗传变化的重点是基因特异性DNA甲基化分析。缺乏对胎盘整体DNA甲基化进行有力研究的研究。但是,一些研究表明,总体DNA甲基化的组织特异性改变与2型糖尿病独立相关。因此,本研究的目的是通过稳健地测量胎盘DNA 5-甲基胞嘧啶(5mC)含量来表征整体胎盘DNA甲基化,并研究胎盘全局DNA甲基化的差异是否与GDM相关。方法采用目前的金标准方法LC-MS / MS对全球DNA甲基化进行定量。在此单中心出生队列研究中,总共分析了1030个胎盘样本。结果患有GDM的母亲表现出显着增加的整体胎盘DNA甲基化(3.22±±0.63比3.00±±0.46±%; p =±0.013;±SD)。双变量对数回归显示,全局胎盘DNA甲基化与GDM的存在高度相关(p =?0.0009)。根据胎盘DNA 5mC水平进行的五分位数分层显示,GDM的频率平均分布在1-4分位数中(2.9-5.3%),而第五个五分位数中的频率显着更高(10.7 %%; p = 0.003) 。调整了产妇年龄,BMI,种族,反复流产和熟悉的糖尿病易感性的双变量逻辑模型清楚地表明了全球胎盘DNA甲基化与GDM之间的独立关联。此外,考虑到DNA甲基化的已知预测因素的ANCOVA模型证实了GDM与胎盘DNA甲基化之间的独立关联。结论这是第一项对1000多个胎盘样本中的胎盘全球DNA甲基化进行了强有力的定量评估的研究。该研究提供了大规模证据,证明胎盘全局DNA甲基化与GDM相关,而与既定的危险因素无关。
展开▼